205 related articles for article (PubMed ID: 32252875)
21. CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice.
Alameda JP; García-García VA; López S; Hernando A; Page A; Navarro M; Moreno-Maldonado R; Paramio JM; Ramírez Á; García-Fernández RA; Casanova ML
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201751
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity.
Ishikawa Y; Tsunoda K; Shibazaki M; Takahashi K; Akasaka T; Masuda T; Maesawa C
Int J Oncol; 2012 Jul; 41(1):53-60. PubMed ID: 22469839
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.
Wu J; Li J; Ren J; Zhang D
Biomed Pharmacother; 2017 Jun; 90():303-310. PubMed ID: 28364602
[TBL] [Abstract][Full Text] [Related]
24. miR‑197‑3p‑induced downregulation of lysine 63 deubiquitinase promotes cell proliferation and inhibits cell apoptosis in lung adenocarcinoma cell lines.
Chen Y; Yang C
Mol Med Rep; 2018 Mar; 17(3):3921-3927. PubMed ID: 29286108
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling.
Zhang G; Miao F; Liu K; Wu J; Xu J
Technol Cancer Res Treat; 2021; 20():15330338211034270. PubMed ID: 34269120
[TBL] [Abstract][Full Text] [Related]
26. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.
Mazar J; DeYoung K; Khaitan D; Meister E; Almodovar A; Goydos J; Ray A; Perera RJ
PLoS One; 2010 Nov; 5(11):e13779. PubMed ID: 21072171
[TBL] [Abstract][Full Text] [Related]
27. Catalytic domain mutation in CYLD inactivates its enzyme function by structural perturbation and induces cell migration and proliferation.
Johari T; Maiti TK
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2081-2089. PubMed ID: 29807073
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of deubiquitinase CYLD enhances therapeutic antibody production in Chinese hamster ovary cells.
Lu Y; Zhou Q; Han Q; Wu P; Zhang L; Zhu L; Weaver DT; Xu C; Zhang B
Appl Microbiol Biotechnol; 2018 Jul; 102(14):6081-6093. PubMed ID: 29766242
[TBL] [Abstract][Full Text] [Related]
29. miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma.
Qiu H; Yuan S; Lu X
Oncol Lett; 2016 Oct; 12(4):2301-2306. PubMed ID: 27698793
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of the Coatomer Protein Complex Subunit beta 2 (COPB2) Gene Targets microRNA-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.
Pu X; Jiang H; Li W; Xu L; Wang L; Shu Y
Med Sci Monit; 2020 Jan; 26():e918382. PubMed ID: 32004259
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2.
Ma ZL; Hou PP; Li YL; Wang DT; Yuan TW; Wei JL; Zhao BT; Lou JT; Zhao XT; Jin Y; Jin YX
Tumour Biol; 2015 Apr; 36(4):2481-90. PubMed ID: 25501507
[TBL] [Abstract][Full Text] [Related]
32. Wnt/β‑catenin signaling is a novel therapeutic target for tumor suppressor CYLD‑silenced glioblastoma cells.
Kanemaru A; Ito Y; Yamaoka M; Shirakawa Y; Yonemaru K; Miyake S; Ando M; Ota M; Masuda T; Mukasa A; Li JD; Saito H; Hide T; Jono H
Oncol Rep; 2023 Nov; 50(5):. PubMed ID: 37772388
[TBL] [Abstract][Full Text] [Related]
33. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-500 sustains nuclear factor-κB activation and induces gastric cancer cell proliferation and resistance to apoptosis.
Zhang L; Ding Y; Yuan Z; Liu J; Sun J; Lei F; Wu S; Li S; Zhang D
Oncotarget; 2015 Feb; 6(4):2483-95. PubMed ID: 25595906
[TBL] [Abstract][Full Text] [Related]
35. CYLD Promotes TNF-
Lin X; Chen Q; Huang C; Xu X
Mediators Inflamm; 2016; 2016():1542786. PubMed ID: 27738385
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma.
Wang Z; Wang X; Zhou H; Dan X; Jiang L; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):263-272. PubMed ID: 29514220
[TBL] [Abstract][Full Text] [Related]
37. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
[TBL] [Abstract][Full Text] [Related]
38. Nonsense-mediated decay factor SMG7 sensitizes cells to TNFα-induced apoptosis via CYLD tumor suppressor and the noncoding oncogene Pvt1.
Yang L; Kraft VAN; Pfeiffer S; Merl-Pham J; Bao X; An Y; Hauck SM; Schick JA
Mol Oncol; 2020 Oct; 14(10):2420-2435. PubMed ID: 32602581
[TBL] [Abstract][Full Text] [Related]
39. Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma.
Jiang CC; Croft A; Tseng HY; Guo ST; Jin L; Hersey P; Zhang XD
Oncogene; 2014 May; 33(20):2577-88. PubMed ID: 23770856
[TBL] [Abstract][Full Text] [Related]
40. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
Chi MN; Guo ST; Wilmott JS; Guo XY; Yan XG; Wang CY; Liu XY; Jin L; Tseng HY; Liu T; Croft A; Hondermarck H; Scolyer RA; Jiang CC; Zhang XD
Oncotarget; 2015 Nov; 6(37):39891-907. PubMed ID: 26573229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
